Zhi Min Shao
Overview
Explore the profile of Zhi Min Shao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hao S, Hou J, Zhang L, Zhou C, Hou Y, Yu K, et al.
BMJ Open
. 2025 Jan;
15(1):e086980.
PMID: 39832996
Introduction: Despite its therapeutic advantages, postmastectomy radiotherapy (PMRT) increases the risk of complications and often leads to poor cosmesis in women undergoing breast reconstruction. Preoperative radiotherapy followed by skin-sparing mastectomy...
2.
Johnston S, Harbeck N, Hegg R, Toi M, Martin M, Shao Z, et al.
J Clin Oncol
. 2020 Sep;
38(34):3987-3998.
PMID: 32954927
Purpose: Many patients with HR+, HER2- early breast cancer (EBC) will not experience recurrence or have distant recurrence with currently available standard therapies. However, up to 30% of patients with...
3.
Guo Y, Zhou Y, Yang X, Shao Z, Ou Z
Biochem Biophys Res Commun
. 2017 Sep;
493(3):1159-1167.
PMID: 28943434
Background: Chemokine (C-X-C motif) ligand 17 (CXCL17) is the latest member of the chemokine family. However, its function in various cancer types is unknown. The G protein-coupled receptor 35 (GPR35)...
4.
Yang X, Lin F, Guo Y, Shao Z, Ou Z
Onco Targets Ther
. 2014 Jun;
7:1033-42.
PMID: 24966685
Chemoresistance is a major cause of cancer treatment failure and leads to a reduction in the survival rate of cancer patients. Phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) and...